Help | Staff Login
2017 Regular Session
Overview
At the request of:
Chief Sponsors: Representative Post, Buehler
Regular Sponsors: Representative Barreto, Parrish (Presession Filed)
Bill Title: Relating to pseudoephedrine; prescribing an effective date.
Catchline/Summary: Deletes requirement that pseudoephedrine be classified as Schedule III controlled substance.
Directs State Board of Pharmacy to adopt rules for dispensing pseudoephedrine. Requires rules to be consistent with provisions of federal Controlled Substances Act that are related to dispensing of pseudoephedrine and federal regulations that implement those provisions. Punishes violation of rules by five years' imprisonment, $125,000 fine, or both. Becomes operative January 1, 2018. Takes effect on 91st day following adjournment sine die.
Chapter Number:
Fiscal Impact: May Have Fiscal Impact, But No Statement Yet Issued
Revenue Impact: May Have Revenue Impact, But No Statement Yet Issued
Measure Analysis: Staff Measure Summary / Impact Statements
Current Location: In House Committee
Current Committee: House Committee On Health Care
Current Subcommittee:
Subsequent Referral(s):
Measure History
Scheduled Events